Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the sale, the director now directly owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Intuitive Surgical Stock Down 0.5 %
ISRG opened at $375.01 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The company has a market cap of $133.02 billion, a P/E ratio of 67.69, a price-to-earnings-growth ratio of 4.83 and a beta of 1.36. The firm’s 50-day moving average price is $386.40 and its 200-day moving average price is $345.19.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 4.84 EPS for the current fiscal year.
Hedge Funds Weigh In On Intuitive Surgical
Analyst Ratings Changes
A number of analysts recently weighed in on ISRG shares. Piper Sandler upped their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research note on Friday, April 19th. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research note on Friday, January 19th. Truist Financial upped their price objective on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Finally, Raymond James increased their price target on shares of Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a research report on Thursday, January 25th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $396.17.
Check Out Our Latest Stock Analysis on ISRG
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- 3 Fintech Stocks With Good 2021 Prospects
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Invest in the FAANG Stocks
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Most Volatile Stocks, What Investors Need to Know
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.